Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $55.49 in the prior trading day, Concentrix Corp (NASDAQ: CNXC) closed at $57.1, up 2.90%. In other words, the price has increased by $2.90 from its previous closing price. On the day, 0.75 million shares were traded. CNXC stock price reached its highest trading level at $57.26 during the session, while it also had its lowest trading level at $55.7563.
Ratios:
Our goal is to gain a better understanding of CNXC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.42. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking. The Stock assigning a Outperform rating and target price of $70. BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for. The Stock was revised from $65 to $85.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 29 ’25 when Twomey Cormac J sold 500 shares for $50.25 per share. The transaction valued at 25,125 led to the insider holds 36,630 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $25,125 on Aug 29 ’25. On Jul 30 ’25, another insider, Twomey Cormac J, who serves as the EVP, Global Ops & Delivery of the company, sold 500 shares for $57.91 each. As a result, the insider received 28,955 and left with 37,130 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 3598733056 and an Enterprise Value of 9073238016. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.68, and their Forward P/E ratio for the next fiscal year is 4.57. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.74. For. The Stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.84. Its current Enterprise Value per Revenue stands at 0.943 whereas that against EBITDA is 6.431.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.59, which has changed by -0.099084914 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $66.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of. The Stock is 7.86%, while the 200-Day Moving Average is calculated to be 13.07%.
Shares Statistics:
. The Stock has traded on average 738.06K shares per day over the past 3-months and 686280 shares per day over the last 10 days, according to various share statistics. A total of 62.93M shares are outstanding, with a floating share count of 44.65M. Insiders hold about 29.15% of the company’s shares, while institutions hold 81.98% stake in the company. Shares short for CNXC as of 1756425600 were 7030374 with a Short Ratio of 9.53, compared to 1753920000 on 7060856. Therefore, it implies a Short% of Shares Outstanding of 7030374 and a Short% of Float of 13.420000000000002.
Earnings Estimates
A detailed examination of Concentrix Corp (CNXC) is currently in progress, with 5.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $3.32, with high estimates of $3.37 and low estimates of $3.28.
Analysts are recommending an EPS of between $11.86 and $11.6 for the fiscal current year, implying an average EPS of $11.69. EPS for the following year is $12.49, with 6.0 analysts recommending between $13.07 and $11.88.
Revenue Estimates
4 analysts predict $2.46B in revenue for the current quarter. It ranges from a high estimate of $2.47B to a low estimate of $2.45B. As of the current estimate, Concentrix Corp’s year-ago sales were $2.39BFor the next quarter, 4 analysts are estimating revenue of $2.52B. There is a high estimate of $2.55B for the next quarter, whereas the lowest estimate is $2.49B.
A total of 5 analysts have provided revenue estimates for CNXC’s current fiscal year. The highest revenue estimate was $9.81B, while the lowest revenue estimate was $9.73B, resulting in an average revenue estimate of $9.77B. In the same quarter a year ago, actual revenue was $9.62BBased on 5 analysts’ estimates, the company’s revenue will be $10.07B in the next fiscal year. The high estimate is $10.26B and the low estimate is $9.9B.
